PKM and neoplasm: In vivo microscopy monitoring in a tumor mouse model showed that the maximum concentration at the tumor site could be reached in 20 min, targeting and effectively inhibiting the gene expression of glycolytic pyruvate kinase isoenzyme (PKM2).